Alliqua BioMedical Announces Changes To Its Board Of Directors

Alliqua BioMedical, Inc.

("Alliqua" or "the Company"), today announced the appointment of Andrew Africk and Gary Restani to its Board of Directors. The Company also announced the departure of David Stefansky and Kenneth D. Pearson from its Board of Directors. Mr. Africk recently formed Searay Capital LLC after 21 years successfully leading private equity and capital markets investments for Apollo Global Management LLC, a leading global alternative asset manager with assets under management exceeding US $150 billion. As a Senior Partner at the firm, Mr. Africk was responsible for Apollo's investments in technology and communications. Mr. Africk currently serves on the Board of Overseers of the University of Pennsylvania School of Engineering, the UCLA Science Board, and is a Trustee of the Trinity School in New York City. Mr. Restani currently serves as Vice Chairman on the Board of Directors for Spiracur Inc., a privately held medical device company focused on the development of innovative wound healing technologies. He recently transitioned from President & CEO of Spiracur Inc. and has more than 40 years of experience in the medical device industry. Prior to joining Spiracur Inc. in 2010, Mr. Restani held both executive and operating positions for global medical device companies including: President and COO of Hansen Medical, President of Convatec, division president at both Zimmer and Smith & Nephew. He attended Sir George Williams University and Loyola University and holds a certificate from Dartmouth College for completing the Tuck School of Business', General Management Executive Program. "We are excited to add these highly experienced individuals to our Board of Directors and expect Alliqua BioMedical to benefit from Andrew's financial acumen and Gary's extensive experience in the medical technology sector," said David Johnson, Chief Executive Officer of Alliqua. "We are also grateful to Dave and Ken for their contributions to the Company during their tenure and wish them both well."